Concepedia

Anna Rudvik

AR

Statistics

Publications

6

Citations

424

H-Index

6

Active since

2018

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (Netherlands)

AstraZeneca (Finland)

University of Gothenburg

AstraZeneca (Australia)

Anna Rudvik is an author at AstraZeneca (Sweden) specializing in medicine, angiogenesis, and drug delivery.

Publications per year

2018–2024

6

Publications

6

Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes

Li‐Ming Gan, Maria Lagerström‐Fermér, Leif Carlsson et al. · Nature Communications · 2019 · 215 citations · Full text

Medicine, Endocrinology, Molecular Medicine +13

Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting

Vesa Anttila, Antti Saraste, Juhani Knuuti et al. · Molecular Therapy · 2022 · 89 citations · Full text

Medicine, Cardiology, Pharmacology +16

Evaluation of surrogate measures of insulin sensitivity - correlation with gold standard is not enough

Anna Rudvik, Marianne Månsson · BMC Medical Research Methodology · 2018 · 76 citations · Full text

Medicine, Biostatistics, Internal Medicine +16

ETESIAN: A PHASE 2B STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF AZD8233, A PCSK9-TARGETED ANTISENSE OLIGONUCLEOTIDE, IN PATIENTS WITH DYSLIPIDEMIA

Michael J. Koren, Alexis Hofherr, Jennifer Schumi et al. · Journal of the American College of Cardiology · 2022 · 18 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

AZD0780, the first oral small molecule PCSK9 inhibitor for the treatment of hypercholesterolemia: Results from a randomized, single-blind, placebo-controlled phase 1 trial

Rick B. Vega, Pavlo Garkaviy, Jane Knöchel et al. · Atherosclerosis · 2024 · 14 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

1–5 of 6